Literature DB >> 28467291

Clinical associations of proinflammatory cytokines, oxidative biomarkers and vitamin D levels in systemic lupus erythematosus.

R Willis1, M Smikle2, K DeCeulaer2, Z Romay-Penabad1, E Papalardo1, P Jajoria1,3, B Harper1,4, V Murthy1, M Petri5, E B Gonzalez1.   

Abstract

Background The abnormal biological activity of cytokines plays an important role in the pathophysiology of both systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). Several studies have highlighted the association of vitamin D and certain pro-inflammatory cytokines with disease activity in SLE. However, there are limited data on the association of vitamin D and antiphospholipid antibodies (aPL) with various proinflammatory biomarkers in these patients and their relative impact on clinical outcomes. Methods The serum levels of several aPL, 25-hydroxy-vitamin D, pro-inflammatory cytokines including IFNα, IL-1β, IL-6, IL-8, IP10, sCD40L, TNFα and VEGF were measured in 312 SLE patients from the Jamaican ( n = 45) and Hopkins ( n = 267) lupus cohorts using commercial Milliplex and ELISA assays. Oxidized LDL/β2glycoprotein antigenic complexes (oxLβ2Ag) and their associated antibodies were also measured in the Jamaican cohort. Healthy controls for oxidative marker and cytokine testing were used. Results Abnormally low vitamin D levels were present in 61.4% and 73.3% of Hopkins and Jamaican SLE patients, respectively. Median concentrations of IP10, TNFα, sCD40L and VEGF were elevated in both cohorts, oxLβ2Ag and IL-6 were elevated in the Jamaican cohort, and IFNα, IL-1β and IL-8 were the same or lower in both cohorts compared to controls. IP10 and VEGF were independent predictors of disease activity, aPL, IP10 and IL-6 were independent predictors of thrombosis and IL-8, and low vitamin D were independent predictors of pregnancy morbidity despite there being no association of vitamin D with pro-inflammatory cytokines. Conclusions Our results indicate that aPL-mediated pro-inflammatory cytokine production is likely a major mechanism of thrombus development in SLE patients. We provide presumptive evidence of the role IL-8 and hypovitaminosis D play in obstetric pathology in SLE but further studies are required to characterize the subtle complexities of vitamin D's relationship with cytokine production and disease activity in these patients.

Entities:  

Keywords:  Antiphospholipid syndrome; cytokines; oxidative biomarkers; systemic lupus erythematosus; thrombosis; vitamin D

Mesh:

Substances:

Year:  2017        PMID: 28467291      PMCID: PMC5493999          DOI: 10.1177/0961203317706557

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  33 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in normal pregnancies and in pregnancies complicated by preeclampsia.

Authors:  Miğraci Tosun; Handan Celik; Bahattin Avci; Erhan Yavuz; Tayfun Alper; Erdal Malatyalioğlu
Journal:  J Matern Fetal Neonatal Med       Date:  2010-08

3.  Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?

Authors:  H Amital; Z Szekanecz; G Szücs; K Dankó; E Nagy; T Csépány; E Kiss; J Rovensky; A Tuchynova; D Kozakova; A Doria; N Corocher; N Agmon-Levin; V Barak; H Orbach; G Zandman-Goddard; Y Shoenfeld
Journal:  Ann Rheum Dis       Date:  2010-05-03       Impact factor: 19.103

Review 4.  Correlation between serum 25(OH)D values and lupus disease activity: an original article and a systematic review with meta-analysis focusing on serum VitD confounders.

Authors:  M Sahebari; N Nabavi; M Salehi
Journal:  Lupus       Date:  2014-06-24       Impact factor: 2.911

5.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.

Authors:  Emily C Baechler; Franak M Batliwalla; George Karypis; Patrick M Gaffney; Ward A Ortmann; Karl J Espe; Katherine B Shark; William J Grande; Karis M Hughes; Vivek Kapur; Peter K Gregersen; Timothy W Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

6.  Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases.

Authors:  J F Camargo; P A Correa; J Castiblanco; J-M Anaya
Journal:  Genes Immun       Date:  2004-12       Impact factor: 2.676

7.  Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study.

Authors:  Jason W Bauer; Michelle Petri; Franak M Batliwalla; Thearith Koeuth; Joseph Wilson; Catherine Slattery; Angela Panoskaltsis-Mortari; Peter K Gregersen; Timothy W Behrens; Emily C Baechler
Journal:  Arthritis Rheum       Date:  2009-10

8.  Vitamin D reverses aPL-induced inflammation and LMWH-induced sFlt-1 release by human trophoblast.

Authors:  Stefan M Gysler; Melissa J Mulla; Meredith Stuhlman; Anna K Sfakianaki; Michael J Paidas; Nancy L Stanwood; Aileen Gariepy; Jan J Brosens; Lawrence W Chamley; Vikki M Abrahams
Journal:  Am J Reprod Immunol       Date:  2014-07-29       Impact factor: 3.886

9.  Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity.

Authors:  Kuniaki Ota; Svetlana Dambaeva; Ae-Ra Han; Kenneth Beaman; Alice Gilman-Sachs; Joanne Kwak-Kim
Journal:  Hum Reprod       Date:  2013-11-24       Impact factor: 6.918

Review 10.  Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools.

Authors:  Jared Klarquist; Zhenyuan Zhou; Nan Shen; Edith M Janssen
Journal:  Mediators Inflamm       Date:  2016-03-30       Impact factor: 4.711

View more
  8 in total

1.  Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers.

Authors:  Seyed Mostafa Monzavi; Aida Alirezaei; Zhaleh Shariati-Sarabi; Jalil Tavakol Afshari; Mahmoud Mahmoudi; Banafsheh Dormanesh; Faezeh Jahandoost; Ali Reza Khoshdel; Ali Etemad Rezaie
Journal:  Inflammopharmacology       Date:  2018-07-10       Impact factor: 4.473

2.  VEGF Profile in Early Undifferentiated Arthritis Cohort.

Authors:  Regina Sakalyte; Loreta Bagdonaite; Sigita Stropuviene; Sarune Naktinyte; Algirdas Venalis
Journal:  Medicina (Kaunas)       Date:  2022-06-20       Impact factor: 2.948

3.  Artemisinin analogue SM934 protects against lupus-associated antiphospholipid syndrome via activation of Nrf2 and its targets.

Authors:  Zemin Lin; Yuting Liu; Li Chen; Shiqi Cao; Yueteng Huang; Xiaoqian Yang; Fenghua Zhu; Wei Tang; Shijun He; Jianping Zuo
Journal:  Sci China Life Sci       Date:  2021-01-19       Impact factor: 6.038

4.  Cytokine and autoantibody clusters interaction in systemic lupus erythematosus.

Authors:  Yovana Pacheco; Julián Barahona-Correa; Diana M Monsalve; Yeny Acosta-Ampudia; Manuel Rojas; Yhojan Rodríguez; Juliana Saavedra; Mónica Rodríguez-Jiménez; Rubén D Mantilla; Carolina Ramírez-Santana; Nicolás Molano-González; Juan-Manuel Anaya
Journal:  J Transl Med       Date:  2017-11-25       Impact factor: 5.531

5.  Effect of add-on hydroxychloroquine therapy on serum proinflammatory cytokine levels in patients with systemic lupus erythematosus.

Authors:  Risa Wakiya; Kiyo Ueeda; Shusaku Nakashima; Hiromi Shimada; Tomohiro Kameda; Mai Mahmoud Fahmy Mansour; Mikiya Kato; Taichi Miyagi; Koichi Sugihara; Mao Mizusaki; Rina Mino; Norimitsu Kadowaki; Hiroaki Dobashi
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

Review 6.  An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases.

Authors:  Claudia Sîrbe; Simona Rednic; Alina Grama; Tudor Lucian Pop
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

Review 7.  Vascular Endothelial Growth Factor Biology and Its Potential as a Therapeutic Target in Rheumatic Diseases.

Authors:  Thi Hong Van Le; Sang-Mo Kwon
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

8.  Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review.

Authors:  Md Asiful Islam; Shahad Saif Khandker; Przemysław J Kotyla; Rosline Hassan
Journal:  Front Immunol       Date:  2020-07-22       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.